BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34160091)

  • 1. Socioeconomic Status and Survival in Nasopharyngeal Carcinoma: A Population-Based Study.
    Brody-Camp S; McCoul ED; Lefante JJ; Aslam R
    Laryngoscope; 2021 Dec; 131(12):2719-2723. PubMed ID: 34160091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy in local-regionally advanced nasopharyngeal carcinoma: A National Cancer Database analysis.
    Tam M; Lee A; Wu SP; Gerber NK; Li Z; Givi B; Hu K; Schreiber D
    Laryngoscope; 2018 Dec; 128(12):2770-2777. PubMed ID: 30133799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
    Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR
    Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    Liu W; Yu B; Luo Y; Li J; Yuan X; Wu S; Liang B; Lv Z; Li Y; Peng X; Lu J; Peng X; Liu X
    BMC Cancer; 2021 May; 21(1):639. PubMed ID: 34051750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
    Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
    Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Stage N3 of the Eighth Edition AJCC Staging System for Nasopharyngeal Carcinoma.
    Pan XB; Qu S; Li L; Chen L; Liang SX; Zhu XD
    Laryngoscope; 2021 Mar; 131(3):535-540. PubMed ID: 32557662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
    Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
    Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study.
    Liu DH; Zhou XY; Pan YG; Chen S; Ye ZH; Chen GD
    Cancer Med; 2020 Feb; 9(4):1287-1297. PubMed ID: 31859464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The racial disparity of nasopharyngeal carcinoma based on the database analysis.
    Zhou L; Shen N; Li G; Ding J; Liu D; Huang X
    Am J Otolaryngol; 2019; 40(6):102288. PubMed ID: 31526630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.
    Hong RL; Hsiao CF; Ting LL; Ko JY; Wang CW; Chang JTC; Lou PJ; Wang HM; Tsai MH; Lai SC; Liu TW
    Ann Oncol; 2018 Sep; 29(9):1972-1979. PubMed ID: 30016391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximal lymph nodal diameter on N stage of nasopharyngeal carcinoma.
    Huang ST; Qu S; Li L; Chen KH; Zhu XD; Pan XB
    Medicine (Baltimore); 2021 Jul; 100(26):e26543. PubMed ID: 34190192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of age on survival of locoregional nasopharyngeal carcinoma: An analysis of the Surveillance, Epidemiology, and End Results program database, 2004-2013.
    Huang SJ; Tang YY; Liu HM; Tan GX; Wang X; Zhang H; Yang F; Yang S
    Clin Otolaryngol; 2018 Oct; 43(5):1209-1218. PubMed ID: 29688619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma.
    Yang L; Gao J; Zhou Y; Tao Z; He J; Yang J; Wang R; Zhang Y; Huang Y; Zhou L; Sun B
    Chemotherapy; 2021; 66(1-2):40-46. PubMed ID: 33601377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.
    Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Li Y; Tang QN; Sun XS; Liang YJ; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    J Natl Compr Canc Netw; 2019 Jun; 17(6):703-710. PubMed ID: 31200353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and prognostic analyses of 110 patients with N3 nasopharyngeal carcinoma.
    Chen J; Liu T; Sun Q; Hu F
    Medicine (Baltimore); 2018 Dec; 97(49):e13483. PubMed ID: 30544441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
    Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
    Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.
    Wang L; Wu Z; Xie D; Lv S; Xia L; Su Y
    Radiat Oncol; 2020 Jul; 15(1):160. PubMed ID: 32615984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chemotherapy on survival in patients with stage T3-4N0M0 nasopharyngeal carcinoma.
    Pan XB; Qu S; Li L; Chen L; Liang SX; Zhu XD
    Clin Otolaryngol; 2021 Jul; 46(4):802-808. PubMed ID: 33580628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database.
    Sun J; Huang Z; Hu Z; Sun R
    J Transl Med; 2017 May; 15(1):116. PubMed ID: 28558725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.